NCT07071519 - A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

July 31, 2034

Study Completion Date

July 31, 2034

Conditions

Ulcerative Colitis

Interventions

DRUG

Risankizumab

Risankizumab intravenous (IV) infusion

DRUG

Risankizumab

Risankizumab subcutaneous (SC) injection

Trial Locations (10)

100

RECRUITING

National Taiwan University Hospital /ID# 269244, Taipei City

407

RECRUITING

Taichung Veterans General Hospital /ID# 269242, Taichung

11000

RECRUITING

University Children's Hospital /ID# 269960, Belgrade

RECRUITING

Institut za zdravstvenu zastitu majke i deteta Srbije Dr Vukan Cupic /ID# 270696, Belgrade-Vračar

21000

RECRUITING

Institute for Child and Youth Health Care of Vojvodina /ID# 269961, Novi Sad

30342

RECRUITING

Childrens Center For Digestive Health Care /ID# 273228, Atlanta

50612

RECRUITING

Pusan National University Yangsan Hospital /ID# 272769, Yangsan

03080

RECRUITING

Seoul National University Hospital /ID# 272852, Seoul

03181

RECRUITING

Kangbuk Samsung Hospital /ID# 273333, Seoul

06351

RECRUITING

Samsung Medical Center /ID# 272862, Seoul